Abstract
Cell surface adhesion molecules, E-cadherin and exon v6 containing CD44 isoforms (CD44v6), were readily found in well-to-moderately differentiated urothelial cell lines but were down-regulated in poorly differentiated cell lines. One hundred and fifteen tumors of transitional cell carcinoma (TCC) were examined with E-cadherin and CD44v6 specific antibodies. Sixty-five (56.5%) tumors exhibited a preserved type while 50 (43.5%) showed a reduced type for CD44v6. Sixty-seven (58.3%) tumors were classified as the preserved type, and 48 (41.7%) were classified as the reduced type for E-cadherin. The staining pattern of E-cadherin was the same as that of CD44v6 in 87.0% (100 of 115) of tumors. The frequency of the reduced type was higher in poorly differentiated carcinomas (32 of 52 for CD44v6, p = 0.001; 27 of 52 for E-cadherin, p = 0.112) and tumors with an invasive growth pattern (22 of 27 for CD44v6, p < 0.001; 20 of 27 for E-cadherin, p < 0.001) than it was in well-differentiated carcinomas and tumors with expansile growth. However, the association with lymph node involvement or distant metastasis did not reach statistical significance. There was no difference in survival in reference to the expression patterns of CD44v6 and E-ca...Continue Reading
References
Jan 1, 1992·Virchows Archiv. A, Pathological Anatomy and Histopathology·H OkaS Hirano
Jan 25, 1991·Cell·L A LiottaW G Stetler-Stevenson
Apr 5, 1991·Cell·U GünthertP Herrlich
Apr 1, 1991·The Journal of Cell Biology·U H FrixenW Birchmeier
Apr 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E P MalaiseM Tubiana
Dec 23, 1993·The New England Journal of Medicine·M C FavrotC Lasset
Feb 1, 1994·Annals of Hematology·M BöhmI Wieland
May 1, 1993·Clinical & Experimental Metastasis·M C BertomeuM R Buchanan
Oct 23, 1993·Lancet·B MayerJ P Johnson
Oct 1, 1993·The Journal of Pathology·M Pignatelli
Jul 1, 1993·The Journal of Cell Biology·M SalmiS Jalkanen
Jan 1, 1993·The Journal of Cell Biology·K H HeiderS T Pals
Citations
Jun 11, 1999·Journal of Surgical Oncology·C H YooJ S Min
Jan 30, 1999·The Journal of Pathology·P LipponenM Eskelinen
Jan 1, 1997·Urological Research·M MüllerK Miller
Mar 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·X Garcia del MuroJ R Germà
Oct 19, 1999·Journal of Pediatric Hematology/oncology·M TakeuchiM Mayumi
Jun 27, 2007·Der Urologe. Ausg. A·T JägerH Rübben
Sep 20, 2011·Urology·Mototsugu MuramakiMasato Fujisawa
Apr 21, 2010·The Journal of Urology·Tobias KlatteAllan J Pantuck
May 11, 2010·Urologic Oncology·Mototsugu MuramakiMasato Fujisawa
Dec 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wei-Chun WengYing-Erh Chou
Nov 7, 1999·The American Journal of Pathology·V TomaJ Roth
May 9, 2001·The Journal of Urology·R R ByrneS P Lerner
Feb 18, 2006·American Journal of Clinical Pathology·Anne ClairotteBernadette Kantelip
Apr 15, 2014·Urology·Shinichi HattoriTakashi Deguchi
Aug 13, 2004·European Urology·Paolo GonteroMaurizio Brausi
Mar 1, 1997·Human Pathology·C CharpinC Allasia
Dec 18, 2002·Critical Reviews in Clinical Laboratory Sciences·David NaorYoram Faitelson
Jul 20, 2002·The Journal of Urology·Mazen A GhanemRien J M Nijman
Feb 18, 1999·The Journal of Urology·M MasudaM Hosaka
Apr 13, 2006·Virchows Archiv : an International Journal of Pathology·Yasuyoshi MiyataHiroshi Kanetake
Dec 21, 2007·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Jitka KuncováVáclav Mandys
May 4, 2004·Oncogene·Kimberly M Rieger-ChristIan C Summerhayes
May 9, 2012·Ultrastructural Pathology·Ola M Omran, Hesham S Ata